Charles Schwab Investment Management Inc Ngm Biopharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 284,649 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
284,649
Previous 278,704 2.13%
Holding current value
$0
Previous $239,000 89.12%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$1.17 - $1.92 $6,955 - $11,414
5,945 Added 2.13%
284,649 $452,000
Q4 2023

Feb 06, 2024
BUY
$0.6 - $1.31 $2,184 - $4,768
3,640 Added 1.32%
278,704 $239,000
Q3 2023

Nov 08, 2023
BUY
$1.05 - $3.37 $3,544 - $11,377
3,376 Added 1.24%
275,064 $294,000
Q2 2023

Aug 09, 2023
SELL
$2.44 - $4.53 $130,383 - $242,065
-53,436 Reduced 16.44%
271,688 $703,000
Q1 2023

May 11, 2023
SELL
$3.72 - $5.4 $10,602 - $15,390
-2,850 Reduced 0.87%
325,124 $1.33 Million
Q4 2022

Feb 13, 2023
BUY
$3.41 - $12.93 $45,745 - $173,455
13,415 Added 4.26%
327,974 $1.65 Million
Q3 2022

Nov 14, 2022
BUY
$12.59 - $17.67 $36,309 - $50,960
2,884 Added 0.93%
314,559 $4.12 Million
Q2 2022

Aug 15, 2022
BUY
$10.58 - $17.5 $128,314 - $212,240
12,128 Added 4.05%
311,675 $4 Million
Q1 2022

May 13, 2022
BUY
$13.81 - $18.6 $263,480 - $354,869
19,079 Added 6.8%
299,547 $4.57 Million
Q4 2021

Feb 11, 2022
BUY
$17.26 - $22.02 $90,131 - $114,988
5,222 Added 1.9%
280,468 $4.97 Million
Q3 2021

Nov 16, 2021
BUY
$20.15 - $26.19 $1.88 Million - $2.44 Million
93,136 Added 51.14%
275,246 $5.79 Million
Q2 2021

Aug 16, 2021
BUY
$15.06 - $30.03 $273,143 - $544,654
18,137 Added 11.06%
182,110 $3.59 Million
Q1 2021

May 17, 2021
BUY
$24.99 - $31.93 $811,525 - $1.04 Million
32,474 Added 24.7%
163,973 $4.77 Million
Q4 2020

Feb 16, 2021
BUY
$16.21 - $31.44 $29,810 - $57,818
1,839 Added 1.42%
131,499 $3.98 Million
Q3 2020

Nov 13, 2020
BUY
$15.59 - $19.97 $742,068 - $950,552
47,599 Added 58.0%
129,660 $2.06 Million
Q2 2020

Aug 14, 2020
BUY
$11.97 - $23.47 $16,207 - $31,778
1,354 Added 1.68%
82,061 $1.62 Million
Q1 2020

May 15, 2020
BUY
$10.0 - $19.51 $16,550 - $32,289
1,655 Added 2.09%
80,707 $996,000
Q4 2019

Feb 07, 2020
BUY
$9.97 - $20.28 $384,752 - $782,625
38,591 Added 95.38%
79,052 $1.46 Million
Q3 2019

Nov 08, 2019
BUY
$13.09 - $18.19 $25,839 - $35,907
1,974 Added 5.13%
40,461 $561,000
Q2 2019

Aug 09, 2019
BUY
$12.56 - $16.6 $483,396 - $638,884
38,487 New
38,487 $564,000

Others Institutions Holding NGM

# of Institutions
77
Shares Held
36.9M
Call Options Held
1.1K
Put Options Held
200
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email